UBS Group AG - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$202,584
-37.8%
64,931
-8.4%
0.00%
Q2 2023$325,509
+26.3%
70,917
+36.2%
0.00%
Q1 2023$257,672
+8.0%
52,055
+19.1%
0.00%
Q4 2022$238,651
+236.1%
43,709
+299.6%
0.00%
Q3 2022$71,000
-22.0%
10,939
-43.3%
0.00%
Q2 2022$91,000
+355.0%
19,303
+583.8%
0.00%
Q1 2022$20,000
-95.5%
2,823
-93.5%
0.00%
Q4 2021$445,000
+293.8%
43,715
+373.4%
0.00%
Q3 2021$113,0009,2340.00%
Other shareholders
MAXCYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders